Advanced Non-Small Cell Lung Cancer #1515 -Reliant

Home
/
Information for Patients
/
Research
/
Clinical Trials
/
Non-Small Cell Lung Cancer #1515

Non-Small Cell Lung Cancer #1515

For elderly patients (≥ 70 years old) with advanced non-small cell lung cancer

Who have not received prior chemotherapy for their advanced disease
Who are not candidates for surgery or radiation therapy

This study is designed to investigate the safety and efficacy of Nab®-Paclitaxel (ABRAXANE®) in combination with Carboplatin as first line treatment.

Contact Candace LeBlanc 508-556-5431 or Marcy Kirkpatrick 508-556-5429 for more information.

For more information about this study:
https://clinicaltrials.gov/ct2/show/NCT02151149